亚太地区组织工程市场预测至 2027 年 - 按材料类型(生物衍生材料、合成材料等)、应用(骨科、肌肉骨骼和脊柱、皮肤、心脏病学和血管、神经学等)划分的 COVID-19 影响和区域分析,和国家

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 163    |    Report Code: TIPRE00013294    |    Category: Life Sciences

Asia Pacific Tissue Engineering Market

亚太地区组织工程市场预计将从2022年的2,177.47 百万美元增长到5,052.49 百万美元到2028年。预计2022年至2028年复合年增长率为12.8%。

 

组织工程和再生医学(TERM)已被提出并发展了30多年。尽管在组织再生方面已经进行了多次成功的尝试,但 TERM 仍处于起步阶段。关于细胞来源的选择、组织特异性材料的开发、专门的生物反应器以及复杂器官的构建,还有许多未解答的基本问题。毕竟,大多数疗法或疗法的目的都是增强组织再生,而干细胞工程为再生医学开辟了一条新途径。组织工程可用于构建各种组织,包括血管、神经组织、皮肤和骨骼。干细胞工程开发了几种涉及新材料、新结构和生物材料新颖表面修饰的技术。此外,还需要深入了解细胞和生物材料之间的相互作用。组织工程研究及其方法的进步导致了生物打印机支架的形成,进而导致了脱细胞器官的形成。对过程的更多研究正在克服以前方法的缺点。提高再生生物学知识、微电子学发展和 3D 打印技术有助于克服这些障碍。此外,细胞疗法是再生医学领域增长最快的领域之一。诺华的 Kymriah 是第一个用于治疗 B 细胞急性白血病的细胞治疗解决方案,这为新兴治疗方法带来了机会。此外,再生医学提供商RepliCel拥有多种再生医学产品在研产品,其中三种产品——RCH-01、RCS-01和RCT-01——正处于开发阶段。此外,Sernova 致力于再生医学技术的开发,并拥有针对各种疾病的庞大产品线,包括糖尿病、A 型血友病和甲状腺功能亢进症。因此,再生医学开发的快速进步为慢性病提供有效的解决方案正在推动市场的增长。

借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动亚太地区组织工程市场在预测期内实现大幅复合年增长率。

 

 亚太地区组织工程市场收入和预测到 2028 年(百万美元)

 

 

亚太组织工程市场细分

 

亚太地区组织工程市场根据材料类型、应用和国家/地区进行细分。根据材料类型,市场分为生物衍生材料、合成材料等。 2022年,生物衍生材料领域占据最大的市场份额。然而,合成材料领域预计在预测期内复合年增长率最高。根据应用,市场分为骨科、肌肉骨骼和医疗领域。脊柱、皮肤和外皮、心脏病学和血管、神经学、癌症、胃肠道和血管学妇科、泌尿科等。到 2022 年,骨科、肌肉骨骼和脊柱细分市场占有最大的市场份额。然而,皮肤和皮肤预计在预测期内,外皮部分将达到市场上最高的复合年增长率。按国家/地区划分,亚太地区组织工程市场分为日本、中国、印度、韩国、澳大利亚和亚太地区其他地区。 2022年,日本占据最大市场份额;预计中国也将在预测期内以最快的复合年增长率增长。

Zimmer Biomet; B. 布劳恩梅尔松根股份公司;史赛克公司;艾伯维公司; Integra生命科学控股公司;器官发生公司;美敦力;百特国际公司;强生服务公司; 3M;和 Cook Biotech Inc. 是亚太组织工程市场的领先公司之一。



Asia Pacific Tissue Engineering Strategic Insights

Strategic insights for Asia Pacific Tissue Engineering involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-tissue-engineering-market-strategic-framework.webp
Get more information on this report

Asia Pacific Tissue Engineering Report Scope

Report Attribute Details
Market size in 2022 US$ 2,177.47 Million
Market Size by 2028 US$ 5,052.49 Million
Global CAGR (2022 - 2028) 12.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 材料类型
  • 生物衍生材料
  • 合成材料
By 应用
  • 骨科
  • 肌肉骨骼和脊柱
  • 皮肤
  • 心脏病学和血管
  • 神经病学
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Stryker Corporation
  • AbbVie, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Inc.
  • Medtronic
  • Baxter International Inc.
  • Johnson and Johnson Services, Inc.
  • 3M
  • Get more information on this report

    Asia Pacific Tissue Engineering Regional Insights

    The regional scope of Asia Pacific Tissue Engineering refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-tissue-engineering-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Tissue Engineering Market

    1. Zimmer Biomet
    2. B. Braun Melsungen AG
    3. Stryker Corporation
    4. AbbVie, Inc.
    5. Integra LifeSciences Holdings Corporation      
    6. Organogenesis Inc.                                                    
    7. Medtronic
    8. Baxter International Inc.
    9. Johnson and Johnson Services, Inc.
    10. 3M
    11. Cook Biotech Inc.
    Frequently Asked Questions
    How big is the Asia Pacific Tissue Engineering Market?

    The Asia Pacific Tissue Engineering Market is valued at US$ 2,177.47 Million in 2022, it is projected to reach US$ 5,052.49 Million by 2028.

    What is the CAGR for Asia Pacific Tissue Engineering Market by (2022 - 2028)?

    As per our report Asia Pacific Tissue Engineering Market, the market size is valued at US$ 2,177.47 Million in 2022, projecting it to reach US$ 5,052.49 Million by 2028. This translates to a CAGR of approximately 12.8% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Tissue Engineering Market report typically cover these key segments-

  • 材料类型 (生物衍生材料, 合成材料)
  • 应用 (骨科, 肌肉骨骼和脊柱, 皮肤, 心脏病学和血管, 神经病学)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Tissue Engineering Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Tissue Engineering Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Tissue Engineering Market?

    The Asia Pacific Tissue Engineering Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Stryker Corporation
  • AbbVie, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Inc.
  • Medtronic
  • Baxter International Inc.
  • Johnson and Johnson Services, Inc.
  • 3M
  • Cook Biotech Inc.
  • Who should buy this report?

    The Asia Pacific Tissue Engineering Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Tissue Engineering Market value chain can benefit from the information contained in a comprehensive market report.